Alaska House Bill HB272

Alaska 2025-2026 Regular Session

• Introduced: 1/23/26
• Refer: 1/23/26
• Report Pass: 4/8/26
• Refer: 4/8/26

Caption

Insurance For Prosthetics & Orthotics

Impact

If passed, HB 272 would significantly alter insurance coverage dynamics for prosthetic and orthotic needs in Alaska. Health care insurers will be required to ensure availability of at least two distinct providers within their network. Furthermore, if in-network options are insufficient, insurers must refer patients to out-of-network providers and cover their costs, thus enhancing access to necessary medical devices. The bill explicitly prevents insurers from imposing higher financial burdens on patients needing prosthetics and orthotics compared to other medical services, thereby aiming to level the playing field in terms of healthcare access.

Summary

House Bill 272 introduces a mandate for insurance companies operating in Alaska to provide coverage for prosthetic and orthotic devices. This bill seeks to ensure that individuals in need of such devices will receive adequate insurance support, on par with federal standards set forth in 42 U.S.C. 1395k to 1395m. Coverage will include not just the initial provision of these devices but also necessary repairs and replacements as dictated by changes to an individual's medical condition or the condition of the device itself. This aspect of the bill highlights the importance of functional independence and quality of life for individuals with limb loss or absence.

Contention

Notably, there are provisions in the bill that require the approval of the United States Department of Health and Human Services to implement certain changes, underlining the bill's reliance on federal frameworks for success. While supporters argue that this mandate will improve the quality of life for individuals with disabilities, there may be concerns about the financial implications for insurers and whether such mandates place undue burdens on healthcare providers or influence the costs of insurance premiums. The ongoing debates surrounding the bill may focus on these aspects as stakeholders assess the balance between accessibility and sustainability of healthcare provision.